In terms of in vitro diagnosis, the applications of Crispr detection in Zika virus and dengue virus detection, HPV screening in cervical cancer and detection of EGFR mutation in non-small cell lung cancer are becoming increasingly mature. This evidence concerns the gene EGFR and non-small cell lung carcinoma.